
Txp Neph @WUNephrology Dir. Kidney Txp @stlouisva co-chair KDWG @clingenresource. AE @KidneyMed. Rsrch #complement #genetics #TMA #AMD #Preeclampsia RT#endorse
Missouri, USA
Joined March 2019
- Tweets8.9K
- Following800
- Followers3.5K
- Likes27.9K
Anuja Java, MD (she/her) retweeted
Thank you to everyone who joined us at the @WashUNephrology Friends and Alumni Reception during #ASNKidneyWeek 2026. What a wonderful evening of reconnecting, reminiscing, and celebrating our nephrology community. Follow link to view photos from the event.
nephrology.wustl.edu/alumni-…
Anuja Java, MD (she/her) retweeted
Register now! Come visit our campus for an exciting 2 days of Nephrogenetics with the most amazing faculty!
Nephrologists, fellows, APPs & genetic counselors: join Silvia Titan and me for #NephroGenetics Update 2026!
Practical cases. Expert discussions. Connections beyond the lecture hall.
Dec 4 & 5 | Mayo Clinic, Jacksonville
Join us in person: tinyurl.com/Nephrogenetics @MayoClinicNeph
Anuja Java, MD (she/her) retweeted
Nephrologists, fellows, APPs & genetic counselors: join Silvia Titan and me for #NephroGenetics Update 2026!
Practical cases. Expert discussions. Connections beyond the lecture hall.
Dec 4 & 5 | Mayo Clinic, Jacksonville
Join us in person: tinyurl.com/Nephrogenetics @MayoClinicNeph
Anuja Java, MD (she/her) retweeted
India has the potential to shape the future of clinical research. But how do we get there?
Join ISN India, American Society of Nephrology and American Nephrologists of Indian Origin for an amazing full-day program on:
🔱Promoting Clinical Trials in India: Landscape, Design & Implementation
From trial design and regulatory frameworks to funding, patient engagement and hands-on workshops.
📅 17 December 2026 | 8:30 AM–5 PM
📍 Hall D, Nautika Hall, Kochi
🎙️ @srigola751 @vjha126 @proychaudhuryMD @Suceena @sishirgang @Vasuragh @AnandhUrmila @Narayansgpgims @drshyambansal @drmanishasahay @MayuriTrivedi80 @Shuchi_Anand @govil_amit @anuja_java @SreejithDr
Let's build stronger clinical research in nephrology!
#ISNCON2026 #ClinicalTrials #NephrologyResearch
Anuja Java, MD (she/her) retweeted
Honored to speak at this great session alongside our distinguished moderators, Drs. Ali Gharavi and @DrRulanParekh, and esteemed mentors and colleagues, @SundaramHariha1, @christiethomas and @anuja_java. @KristaLentine, @MonaDoshiMD and @PuneetSoodMD @ASNKidney @AST_info 🙏🥰🙏
Anuja Java, MD (she/her) retweeted
Thanks 🙏🏽 to everyone who visited @IsabellaLerma14
#KidneyWk
Anuja Java, MD (she/her) retweeted
Don't miss @anuja_java - moderator of session on complement in glomerular diseases. #KidneyWk
See more on our @WashUNephrology calendar: nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
Visit @anuja_java's session today at #KidneyWk to hear her presentation on complement-mediated kidney diseases and transplantation.
See more on our@WashUNephrology calendar: nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
📍 Happening now at @ASNKidney KidneyWeek in Denver!
Join us for the ASN OncoNephrology Program for a day of cutting-edge science, emerging cancer therapies, and practical insights.
Are your ready? 🫘
@onconeph @rc_oncneph @SheronLatcha @ShrutiGkidney @PaulHannaMD @hhashmi87
Anuja Java, MD (she/her) retweeted
Don’t miss @anuja_java's presentation and panel at #KidneyWk 2026 Early Program!
Explore the full @WashUNephrology calendar: nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
Denver, here we come! Check out our 2026 ASN #KidneyWk @WashUNephrology calendar of presentations, posters, and more!
nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
How much kidney function is enough for the right dose?
This session by @PaulHannaMD and Thomas Nolin looks at individualising GFR assessment and multidisciplinary dose adjustment of anticancer therapies in CKD and ESKD.
@rc_oncneph @onconeph @SheronLatcha @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
🩸Thrombotic Microangiopathy in Patients with Cancer 🩸
Cancer associated TMA can be complex, especially when complement activation is involved.
This session by @anuja_java will explore the role of complement regulation and inhibition in these patients.
@rc_oncneph @onconeph
Anuja Java, MD (she/her) retweeted
Our next session?
🩺Case Based Debates in Onconephrology ➡️ To Transplant or Not to Transplant in patients with cancers ?
Discussants : Nadia Al Haddad, @hhashmi87 @anuja_java @nymurakami @itunuowoyemi
Register 🔗: asn-online.org/education/kid…
@rc_oncneph @onconeph @SheronLatcha
Anuja Java, MD (she/her) retweeted
🦀🫘👩🏻⚕️Kidney Transplant Onconephrology
How do we approach cancer treatment in KTRs?
Dr Murakami @nymurakami discusses immunotherapy, engineered cellular therapies and management of PTLDs
Register 🔗 : asn-online.org/education/kid…
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
✨Session 4: AKI and Electrolyte Disturbances in Cancer and Novel Targeted Therapies
Cancer therapies continue to evolve, and so do the kidney complications we see with them.
🎙️ : @ZiolkowskiSusan
@onconeph @SheronLatcha @MaulinPatelDO
Register : asn-online.org/education/kid…
Anuja Java, MD (she/her) retweeted
Next off, we discuss Novel Radioligand Therapies and Nephrotoxicity
This session by @rc_oncneph will focus on these newer therapies and an important question for nephrologists: what do we need to know about their renal effects?
@onconeph @SheronLatcha @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
Explore Genetics in Kidney Care
The Genetics in Kidney Health Summit Recordings Showcase brings together established approaches, emerging research, and patient stories.
Watch on demand: vimeo.com/showcase/12432086
Anuja Java, MD (she/her) retweeted
Update on Paraproteinemia and Kidney Pathologies: Monoclonal vs. Monotypic
This session by Lihong Bu will look at monoclonal vs. monotypic patterns and the renal pathologies we need to recognise.
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
Here’s the ASN Onconephrology Program at #KidneyWeek 2026 in Denver.
A full day covering new therapies, kidney complications of cancer treatment, transplant, pathology, immunotherapy, & case-based discussions.
Hope to see many of you there!
@onconeph @rc_oncneph @SheronLatcha



























